Terns Pharmaceuticals, Inc.

NasdaqGS:TERN Stock Report

Market Cap: US$497.7m

Terns Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TERN Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Dec 24BuyUS$110,468Amy BurroughsIndividual15,450US$7.15
12 Sep 24BuyUS$4,999,995Hongbo LuIndividual476,190US$10.50
01 Aug 24SellUS$47,148Jill QuigleyIndividual6,143US$7.68
16 Jul 24SellUS$561,640OrbiMed Advisors LLCCompany56,164US$10.00
31 May 24BuyUS$21,272Mark VignolaIndividual4,791US$4.44
31 May 24BuyUS$21,272Seokho YoonIndividual4,791US$4.44
03 Apr 24SellUS$2,188,226Vivo Capital, LLCCompany329,121US$6.99

Insider Trading Volume

Insider Buying: TERN insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TERN?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders566,4390.667%
General Public1,708,4922.01%
Hedge Funds6,223,5447.33%
VC/PE Firms20,035,27523.6%
Institutions56,405,10566.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 37.5%.

Top Shareholders

Top 25 shareholders own 81.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.9%
OrbiMed Advisors LLC
7,562,971US$44.3m-0.74%0.66%
8.12%
Vivo Capital, LLC
6,895,746US$40.4m0%3.61%
7.33%
Soleus Capital Management, L.P.
6,223,544US$36.5m25.8%2.96%
6.57%
Deep Track Capital, LP
5,576,558US$32.7m-8.58%1.07%
5.53%
BlackRock, Inc.
4,698,771US$27.5m14%no data
4.32%
Citadel Advisors LLC
3,673,226US$21.5m152%0.02%
4.01%
VR Adviser, LLC
3,410,058US$20.0m0%1.07%
3.95%
The Vanguard Group, Inc.
3,356,814US$19.7m45.9%no data
3.87%
Schonfeld Strategic Advisors LLC
3,289,826US$19.3m45%0.16%
3.42%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
2,901,566US$17.0m0%5.36%
3.41%
Point72 Asset Management, L.P.
2,894,093US$17.0m7.57%0.04%
2.51%
Avidity Partners Management, L.P.
2,133,872US$12.5m0%0.75%
2.46%
Driehaus Capital Management LLC
2,091,801US$12.3m93%0.08%
2.37%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
2,012,183US$11.8m170%no data
1.94%
ExodusPoint Capital Management, LP
1,648,131US$9.7m0%0.1%
1.86%
Millennium Management LLC
1,578,534US$9.3m38.4%0.01%
1.74%
T. Rowe Price Group, Inc.
1,475,679US$8.6m5,430%no data
1.59%
Superstring Capital Management LP
1,348,546US$7.9m41%8.93%
1.42%
Geode Capital Management, LLC
1,207,479US$7.1m7.63%no data
1.38%
FMR LLC
1,172,524US$6.9m-57.6%no data
1.32%
State Street Global Advisors, Inc.
1,116,991US$6.5m-5.09%no data
1.23%
Bellevue Asset Management AG
1,042,135US$6.1m0%0.08%
0.92%
Morgan Stanley, Investment Banking and Brokerage Investments
779,033US$4.6m150%no data
0.89%
Tavistock Life Sciences
752,000US$4.4m0%0.32%
0.88%
Russell Investment Management, LLC
744,687US$4.4m14.9%0.01%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 13:00
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Terns Pharmaceuticals, Inc. is covered by 11 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Etzer DaroutBMO Capital Markets Equity Research
Corinne JohnsonGoldman Sachs
Corinne JohnsonGoldman Sachs